Retrieve available abstracts of 8 articles: HTML format
Single Articles
February 2025
HARADA K, Sakamoto N, Kitaoka T, Nakamura Y, et al PI3 expression predicts recurrence after chemotherapy with DNA-damaging drugs in
gastric cancer.
J Pathol. 2025 Feb 20. doi: 10.1002/path.6400. PubMedAbstract available
June 2024
ZHOU Y, Li S, Hu Y, Xu X, et al Multi-regional sequencing reveals the genetic and immune heterogeneity of
non-cancerous tissues in gastric cancer.
J Pathol. 2024 Jun 6. doi: 10.1002/path.6297. PubMedAbstract available
April 2024
MONSTER JL, Kemp LJ, Busslinger GA, Vliem MJ, et al Cell division-dependent dissemination following E-cadherin loss underlies
initiation of diffuse-type gastric cancer.
J Pathol. 2024 Apr 4. doi: 10.1002/path.6277. PubMedAbstract available
March 2024
DUAN S, Sawyer TW, Witten BL, Song H, et al Spatial profiling reveals tissue-specific neuro-immune interactions in
gastroenteropancreatic neuroendocrine tumors.
J Pathol. 2024;262:362-376. PubMedAbstract available
June 2023
CHOI S, Kim H, Heo YJ, Kang SY, et al PIK3CA mutation subtype delineates distinct immune profiles in gastric carcinoma.
J Pathol. 2023 Jun 21. doi: 10.1002/path.6134. PubMedAbstract available
ZHANG J, Chen B, Wang Y, Liu X, et al The E2F1-HOXB9/PBX2-CDK6 axis drives gastric tumorigenesis and serves as a
therapeutic target in gastric cancer.
J Pathol. 2023 Jun 5. doi: 10.1002/path.6091. PubMedAbstract available
May 2023
GOLDENRING JR Spasmolytic polypeptide-expressing metaplasia (SPEM) cell lineages can be an
origin of gastric cancer.
J Pathol. 2023 May 5. doi: 10.1002/path.6089. PubMedAbstract available
April 2023
YING L, Liu P, Ding Z, Wray-McCann G, et al Anti-CD40L therapy prevents the formation of precursor lesions to gastric B-cell
MALT lymphoma in a mouse model.
J Pathol. 2023;259:402-414. PubMedAbstract available